Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

Pharmaceutical Consulting Services: How to Choose the Right Partner

Jun 16, 2026By Sreejith Kanhirangadan

SK

Understanding Pharmaceutical Consulting Services

In the ever-evolving pharmaceutical industry, consulting services play a crucial role in navigating the complexities of regulations, research, and market dynamics. These services can encompass a range of areas, including regulatory compliance, clinical trials, market access, and more. Choosing the right consulting partner is essential for ensuring successful project outcomes and maintaining competitive advantage.

pharmaceuticals consulting

Why You Need a Pharmaceutical Consulting Partner

The pharmaceutical sector is characterized by stringent regulations and rapid advancements. A knowledgeable consulting partner can provide expert guidance and strategic insights to help your organization stay ahead. By leveraging their expertise, you can streamline operations, minimize risks, and optimize resource allocation, ultimately enhancing your company's performance.

Consultants bring a wealth of experience and a fresh perspective to your projects. They can identify potential pitfalls and opportunities, ensuring that your strategies are robust and forward-thinking. Whether you're a start-up aiming to enter the market or an established company seeking to innovate, the right partner can make all the difference.

Key Considerations When Choosing a Consulting Partner

When selecting a pharmaceutical consulting partner, there are several important factors to consider. First, evaluate their experience and expertise in your specific area of need. A firm with a proven track record in your domain can provide tailored advice and solutions that align with your objectives.

business meeting

Reputation and References

Research the firm's reputation in the industry. Look for client testimonials, case studies, and references to gauge their credibility and reliability. A reputable consulting partner will have a history of successful collaborations with companies similar to yours.

Additionally, consider seeking recommendations from peers or industry associations. These insights can provide valuable information about the consultant’s capabilities and the quality of their services.

Flexibility and Collaboration

Effective pharmaceutical consulting requires a collaborative approach. Choose a partner who values open communication and is willing to work closely with your team. Flexibility in adapting to your organization's unique needs and culture is also crucial for a successful partnership.

teamwork collaboration

Evaluating Cost and Value

While cost is an important consideration, it should not be the sole factor in your decision. Evaluate the overall value that the consulting partner offers. A more expensive consultant with specialized expertise and a strong track record may provide better long-term value than a less costly option.

Consider the potential ROI and the impact their services could have on your business. A well-chosen partner can contribute significantly to your company's growth and success.

Final Thoughts

Choosing the right pharmaceutical consulting partner is a strategic decision that requires careful consideration. By focusing on experience, reputation, collaboration, and value, you can find a partner that aligns with your goals and helps drive your organization forward.

Remember, the right consultant is not just a service provider but a valuable ally in your journey towards innovation and excellence in the pharmaceutical industry.